You are here

JNJ

Janssen drops the BACE as Alzheimer’s candidate joins fail list

Janssen drops the BACE as Alzheimer’s candidate joins fail list

Fierce Biotech

BACE inhibitors

Alzheimer's disease

Flag link:

FDA calls out 39 drug companies for allegedly blocking access to generics

FDA calls out 39 drug companies for allegedly blocking access to generics

Stat

Valeant Pharmaceuticals

Flag link:

Stryker, J&J and Abbott ranked as top companies to work at in the U.S.

Stryker, J&J and Abbott ranked as top companies to work at in the U.S.

Medical Devices and Diagnostics Industry

Flag link:

A Huge Decision Is on Tap for This Little Biotech Stock

A Huge Decision Is on Tap for This Little Biotech Stock

Yahoo/Motley Fool

Flag link:

DePuy Synthes touts improved functionality, shorter hospital stays with Attune knee

DePuy Synthes touts improved functionality, shorter hospital stays with Attune knee

Mass Device

Flag link:

J&J’s DePuy Synthes acquires Medical Enterprises Distribution assets

J&J’s DePuy Synthes acquires Medical Enterprises Distribution assets

Mass Device

Medical Enterprises Distribution

Flag link:

Janssen obtains FDA approval for Darzalex (multiple myeloma)

Janssen obtains FDA approval for Darzalex (multiple myeloma)

GoinPharma

Multiple Myeloma

Flag link:

Johnson & Johnson unveils new Asia-Pacific headquarters in Singapore

Johnson & Johnson unveils new Asia-Pacific headquarters in Singapore

HRM Asia

Flag link:

J&J’s Janssen touts Ph3 data for antidepressant nasal spray

J&J’s Janssen touts Ph3 data for antidepressant nasal spray

Drug Delivery Business News

Flag link:

With hits and misses in first pivotal trials, J&J confidently maps a path to the FDA with its major depression med esketamine

With hits and misses in first pivotal trials, J&J confidently maps a path to the FDA with its major depression med esketamine

Endpoints

major depression

Flag link:

J&J’s Janssen acquires cancer-killing virus tech

J&J’s Janssen acquires cancer-killing virus tech

Drug Delivery Business News

oncolytic viruses

Flag link:

Report: Johnson & Johnson wins appeal in $151m hip verdict

Report: Johnson & Johnson wins appeal in $151m hip verdict

Mass Device

Flag link:

Report: Johnson & Johnson sees Vision Care biz grow, looks to expand beyond contacts

Report: Johnson & Johnson sees Vision Care biz grow, looks to expand beyond contacts

Mass Device

Flag link:

Johnson & Johnson Develops First Light-Adaptive Contact Lenses

Johnson & Johnson Develops First Light-Adaptive Contact Lenses

Xtalks

Transitions Optical

Flag link:

3 Drugs That Are Moving the Needle at Johnson & Johnson

3 Drugs That Are Moving the Needle at Johnson & Johnson

Motley Fool

Flag link:

J&J dumps a failed PhIII antibiotic program picked up in Actelion buyout

J&J dumps a failed PhIII antibiotic program picked up in Actelion buyout

Endpoints

Flag link:

Johnson & Johnson tops 1Q views on sales spike, but net dips

Johnson & Johnson tops 1Q views on sales spike, but net dips

Yahoo/AP

Flag link:

JNJ's Esketamine Demonstrates Significantly Rapid Improvements in Depressive Symptoms and Suicidality in Phase 2 Study

JNJ's Esketamine Demonstrates Significantly Rapid Improvements in Depressive Symptoms and Suicidality in Phase 2 Study

CP Wire

major depression

Flag link:

JNJ's Esketamine Demonstrates Significantly Rapid Improvements in Depressive Symptoms and Suicidality in Phase 2 Study

major depression

Flag link:

Johnson & Johnson (JNJ) Expected to Announce Quarterly Sales of $19.38 Billion

Johnson & Johnson (JNJ) Expected to Announce Quarterly Sales of $19.38 Billion

Daily Political

Flag link:

Pages